NCT04529889 GDM and Its Consequences in Mothers and Offsprings
| NCT ID | NCT04529889 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guangzhou Women and Children's Medical Center |
| Condition | Gestational Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 7,000 participants |
| Start Date | 2012-02-01 |
| Primary Completion | 2038-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 7,000 participants in total. It began in 2012-02-01 with a primary completion date of 2038-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Gestational diabetes mellitus (GDM) is one of the most common disorders which occured during pregnancy. GDM is not only associated with short-term maternal and fetal adverse outcomes, but also related to a wide range of long-term consequences for both mother and child. The GDM and Its Consequences for mothers and offsprings (GDMCMO) aims to establish a cohort to follow both maternal and offsprings'short-term and long-term outcomes, including fetal malformations including congenital heart diseases, birth weight, preterm birth, caesarean section delivery, body growth and neurodevelopment after birth, obesity, type 2 diabetes and impaired insulin sensitivity and secretion, lung health and allergic diseases later in life for offspring, as well as future type 2 diabetes and cardiovascular risk factors for mother after delivery. Biological samples including blood and tissue samples of mothers and children are also collected during pregnancy and after delivery.
Eligibility Criteria
Inclusion Criteria: 1. Pregnant women diagnosed with gestational diabetes mellitus 2. Pregnant women intended to eventually deliver in Guangzhou Women and Children's Medical Center 3. Permanent residents or families intended to remain in Guangzhou with their child for no less than 3 years Exclusion Criteria: 1. Women with pre-gestational diabetes mellitus 2. Women with chronic hypertension or kidney disease
Contact & Investigator
Xiu Qiu, MD,PhD
PRINCIPAL INVESTIGATOR
Guangzhou Women and Children's Medical Center, China
Frequently Asked Questions
Who can join the NCT04529889 clinical trial?
This trial is open to participants of all sexes, studying Gestational Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04529889 currently recruiting?
Yes, NCT04529889 is actively recruiting participants. Contact the research team at qxiu0161@163.com for enrollment information.
Where is the NCT04529889 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT04529889 clinical trial?
NCT04529889 is sponsored by Guangzhou Women and Children's Medical Center. The principal investigator is Xiu Qiu, MD,PhD at Guangzhou Women and Children's Medical Center, China. The trial plans to enroll 7,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.